The Medical Advisor

Executive Summary Bio-individualised optimization in 2026 is the transition from "one-size-fits-all" wellness to  real-time biological engineering . By integrating AI-driven wearables, epigenetic testing, and continuous biomarker monitoring, individuals can now tailor nutrition, recovery, and longevity protocols to their unique genetic and metabolic signatures. 1. The Shift from Passive Tracking to Active Bio-Management In the 2026 landscape, "General Health" is viewed as a statistical failure. We focus on N-of-1 Biology , where your data is the only source of truth. Epigenetic Precision: Moving beyond DNA to measure biological age via DunedinPACE methylation clocks. The Intelligence Layer:  Using AI to cross-reference  blood panel data  with daily stress markers to predict burnout 48 hours in advance. Metabolic Individuality:  Recognizing that "healthy" foods (like oats or bananas) can cause inflammatory glucose spikes in specific individuals while remai...

Introduction The potential applications of Ivermectin and Benzimidazole (Fenbendazole and Mebendazole) in cancer treatment have sparked significant interest online, with growing communities exploring these compounds for therapeutic use. While both have roots in anti-parasitic medicine, emerging research and anecdotal evidence suggest they may offer benefits in combating colorectal cancers. The main goal with this article is to provide as much clear information as possible for someone dealing with colorectal cancer. This article deals with the basis and practical approach to using Fenbendazole and Ivermectin for colorectal cancer. Can Fenbendazole and Ivermectin play a key role in treating Stage 4 Colorectal Cancer? Several peer-reviewed papers and case studies (below) strongly suggest that it might: Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer Ivermect...